Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism RPA1 inhibitors(replication protein A1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H14Cl4N2O3S |
InChIKeyHQDYAIBLPJRECW-UHFFFAOYSA-N |
CAS Registry3026716-22-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Trypanosomiasis, African | Preclinical | US | 20 Jul 2023 |